Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
This study is currently recruiting participants.
Verified May 2013 by National Institute of Allergy and Infectious Diseases (NIAID)
Study NCT01571414
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received on March 20, 2012.
Last Updated on May 3, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
